Westlake Chemical Corporation (WLK)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NYSE
Market Cap: $8.13B
Last updated: Nov 17, 2026 at 11:06 AM ET
Westlake Chemical Corporation (WLK) Stock Forecast
Analysts expect Westlake Chemical (WLK) to earn $1.57 per share in the fiscal year ending Dec 31, 2026, on revenue of $11.61B. Of 17 analysts, 6 rate the stock Buy or Strong Buy, 10 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 10 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 17 ratings average 2.65, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 35% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 2 | 11.8% |
| Buy | 4 | 23.5% |
| Hold | 10 | 58.8% |
| Sell | 0 | 0.0% |
| Strong Sell | 1 | 5.9% |
- Consensus
- Hold
- Total analysts
- 17
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus falls 0.6% and revenue estimates rise 1.2%.
- Fiscal year ending Dec 31, 2026
- $1.57
- EPS consensus, revenue $11.61B
- Fiscal year ending Dec 31, 2027
- $1.56
- EPS consensus, revenue $11.75B
- Next report
- Feb 22, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.57 | $1.24 to $1.99 | 12 | $11.61B | $11.22B to $11.86B | 15 |
| Dec 31, 2027 | $1.56 | $0.16 to $2.22 | 13 | $11.75B | $10.52B to $12.40B | 15 |
Quarterly Estimates
The EPS consensus rises from -$0.02 for the quarter ending Dec 31, 2026 to $0.09 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.02 | -$0.45 to $0.45 | 18 | $2.64B | $980.00M to $3.11B | 17 |
| Mar 31, 2027 | $0.09 | -$0.08 to $0.26 | 5 | $2.80B | $2.62B to $2.90B | 4 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 1 upward and 21 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 10 |
| Fiscal year ending Dec 31, 2027 | 0 | 10 |
| Quarter ending Mar 31, 2027 | 1 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 51.4% from $3.23.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $1.57 | $1.97 | $2.53 | $3.20 | $3.23 | -51.6% |
| Fiscal year ending Dec 31, 2027 | $1.56 | $2.37 | $2.83 | $3.25 | $3.36 | -53.5% |
| Quarter ending Mar 31, 2027 | $0.09 | $0.46 | $0.49 | $0.36 | $0.41 | -78.0% |
Frequently Asked Questions About WLK
What is the WLK stock forecast?
Consensus analyst estimates put Westlake Chemical's EPS at $1.57 for the fiscal year ending Dec 31, 2026, on revenue of $11.61B. The consensus rating from 17 analysts is Hold.
How do analysts rate WLK stock?
Of 17 analysts covering Westlake Chemical, 2 rate it Strong Buy, 4 Buy, 10 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from WLK next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $1.57, with estimates from $1.24 to $1.99 from 12 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.56, with estimates from $0.16 to $2.22 from 13 analysts.
What revenue do analysts expect from Westlake Chemical next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $11.61B, with estimates from $11.22B to $11.86B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $11.75B, with estimates from $10.52B to $12.40B.
How many analysts cover WLK?
17 analysts rate Westlake Chemical stock, and 12 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
WLK pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors